-7.7%
MDB vs MRNA
+945.0%
-952.7%
-48.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.1% | +13.1% | -15.2% | -2.5% |
| 7D | -16.5% | +20.6% | -37.2% | -17.1% |
| 30D | -8.6% | +27.1% | -35.7% | -9.3% |
| 3M | -13.6% | +353.4% | -367.0% | -19.2% |
| 6M | +24.1% | +446.3% | -422.2% | +14.6% |
| YTD | -21.8% | +776.2% | -797.9% | -32.0% |
| 1Y | -7.7% | +987.9% | -995.6% | -22.8% |
| All | -7.7% | +945.0% | -952.7% | -22.8% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling